Peer-Review ""Failures""

I applaud NIH's examination of the peer review process (The Scientist, August 8, page 1) and the agency's attempt at procedural reforms aimed at funding the best possible science. At bottom, much of the concern with the peer-review system at NIH, as with professional journals, lies in the inescapable fact that the same small pool of experts serves as both reviewer and reviewee for an extended time in many domains, facilitating two inappropriate practices—backslapping and backbiting. The sm

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The plan to look at NIH peer review's "rate of failure" by a retrospective examination of scientific advances and their funding will help identify projects that typically succeeded in obtaining funding elsewhere. However, the study cannot estimate the extent of review failure that might be attributable to premature departure from the field of promising investigators who had been denied NIH funding. The potential discoveries of such individuals remain as incalculable as the potential discoveries of buried soldiers. Some rough estimation of this area of failure might be obtained if the study could be augmented by an examination of the current performance and attitudes of such former investigators. But because science itself addresses the unknown and because only a small proportion of research projects bear a significant impact on the future course of discovery, we can never be certain that a particular system of peer review or a particular set of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • William Cooper

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo
Characterizing Immune Memory to COVID-19 Vaccination

Characterizing Immune Memory to COVID-19 Vaccination

10X Genomics
Optimize PCR assays with true linear temperature gradients

Applied Biosystems™ VeriFlex™ System: True Temperature Control for PCR Protocols

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo